79 related articles for article (PubMed ID: 19551145)
1. Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration.
Shemon AN; Eves EM; Clark MC; Heil G; Granovsky A; Zeng L; Imamoto A; Koide S; Rosner MR
PLoS One; 2009 Jun; 4(6):e6028. PubMed ID: 19551145
[TBL] [Abstract][Full Text] [Related]
2. RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13.
Datar I; Feng J; Qiu X; Lewandowski J; Yeung M; Ren G; Aras S; Al-Mulla F; Cui H; Trumbly R; Arudra SK; De Las Casas LE; de la Serna I; Bitar MS; Yeung KC
PLoS One; 2015; 10(8):e0134494. PubMed ID: 26308852
[TBL] [Abstract][Full Text] [Related]
3. Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction.
Klysik J; Theroux SJ; Sedivy JM; Moffit JS; Boekelheide K
Cell Signal; 2008 Jan; 20(1):1-9. PubMed ID: 17706925
[TBL] [Abstract][Full Text] [Related]
4. PEBP1/RKIP behavior: a mirror of actin-membrane organization.
Schoentgen F; Jonic S
Cell Mol Life Sci; 2020 Mar; 77(5):859-874. PubMed ID: 31960115
[TBL] [Abstract][Full Text] [Related]
5. RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity.
Touboul R; Baritaki S; Zaravinos A; Bonavida B
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944867
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Marine-Derived Natural Products as Raf Kinase Inhibitory Protein (RKIP)-Binding Ligands.
Parate S; Kumar V; Hong JC; Lee KW
Mar Drugs; 2021 Oct; 19(10):. PubMed ID: 34677480
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Binding Interaction of Raf Kinase Inhibitory Protein With the N-Terminal of C-Raf Through Molecular Docking and Molecular Dynamics Simulation.
Parate S; Rampogu S; Lee G; Hong JC; Lee KW
Front Mol Biosci; 2021; 8():655035. PubMed ID: 34124147
[TBL] [Abstract][Full Text] [Related]
8. Targeting Raf Kinase Inhibitory Protein Regulation and Function.
Yesilkanal AE; Rosner MR
Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30181452
[TBL] [Abstract][Full Text] [Related]
9. SSPaQ: A Subtractive Segmentation Approach for the Exhaustive Parallel Quantification of the Extent of Protein Modification at Every Possible Site.
Gabant G; Boyer A; Cadene M
J Am Soc Mass Spectrom; 2016 Aug; 27(8):1328-43. PubMed ID: 27245456
[TBL] [Abstract][Full Text] [Related]
10. RKIP structure drives its function: a three-state model for regulation of RKIP.
Skinner JJ; Rosner MR
Crit Rev Oncog; 2014; 19(6):483-8. PubMed ID: 25597357
[TBL] [Abstract][Full Text] [Related]
11. RKIP contributes to IFN-γ synthesis by CD8+ T cells after serial TCR triggering in systemic inflammatory response syndrome.
Wright KT; Vella AT
J Immunol; 2013 Jul; 191(2):708-16. PubMed ID: 23761631
[TBL] [Abstract][Full Text] [Related]
12. RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy.
Martinho O; Pinto F; Granja S; Miranda-Gonçalves V; Moreira MA; Ribeiro LF; di Loreto C; Rosner MR; Longatto-Filho A; Reis RM
PLoS One; 2013; 8(3):e59104. PubMed ID: 23527098
[TBL] [Abstract][Full Text] [Related]
13. RKIP regulates MAP kinase signaling in cells with defective B-Raf activity.
Zeng L; Ehrenreiter K; Menon J; Menard R; Kern F; Nakazawa Y; Bevilacqua E; Imamoto A; Baccarini M; Rosner MR
Cell Signal; 2013 May; 25(5):1156-65. PubMed ID: 23416466
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylenthanolamine Binding Protein aka Raf Kinase Inhibitor Protein: A Brief History of Its Discovery and the Remarkable Diversity of Biological Functions.
Sedivy JM
For Immunopathol Dis Therap; 2011; 2(1):1-12. PubMed ID: 23227430
[TBL] [Abstract][Full Text] [Related]
15. Ligand binding study of human PEBP1/RKIP: interaction with nucleotides and Raf-1 peptides evidenced by NMR and mass spectrometry.
Tavel L; Jaquillard L; Karsisiotis AI; Saab F; Jouvensal L; Brans A; Delmas AF; Schoentgen F; Cadene M; Damblon C
PLoS One; 2012; 7(4):e36187. PubMed ID: 22558375
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas.
Martinho O; Granja S; Jaraquemada T; Caeiro C; Miranda-Gonçalves V; Honavar M; Costa P; Damasceno M; Rosner MR; Lopes JM; Reis RM
PLoS One; 2012; 7(1):e30769. PubMed ID: 22292035
[TBL] [Abstract][Full Text] [Related]
17. Locostatin Disrupts Association of Raf Kinase Inhibitor Protein With Binding Proteins by Modifying a Conserved Histidine Residue in the Ligand-Binding Pocket.
Beshir AB; Argueta CE; Menikarachchi LC; Gascón JA; Fenteany G
For Immunopathol Dis Therap; 2011; 2(1):47-58. PubMed ID: 21709760
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.
Shemon AN; Heil GL; Granovsky AE; Clark MM; McElheny D; Chimon A; Rosner MR; Koide S
PLoS One; 2010 May; 5(5):e10479. PubMed ID: 20463977
[TBL] [Abstract][Full Text] [Related]
19. The oxazolidinone derivative locostatin induces cytokine appeasement.
Ménoret A; McAleer JP; Ngoi SM; Ray S; Eddy NA; Fenteany G; Lee SJ; Rossi RJ; Mukherji B; Allen DL; Chakraborty NG; Vella AT
J Immunol; 2009 Dec; 183(11):7489-96. PubMed ID: 19917702
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
